MAR
57
3
JNPR
59
3
CMS
57
2
NEM
30
2
TSCO
42
4
EW
55
5
ADP
57
2
CPB
24
2
BAC
38
3
EXR
42
5
DD
44
2
PNW
55
3
NRG
32
5
DGX
28
4
AA
27
5
XYL
29
4
JCI
44
7
GWW
50
9
FOXA
67
5
BAX
38
2
MAR
57
3
JNPR
59
3
CMS
57
2
NEM
30
2
TSCO
42
4
EW
55
5
ADP
57
2
CPB
24
2
BAC
38
3
EXR
42
5
DD
44
2
PNW
55
3
NRG
32
5
DGX
28
4
AA
27
5
XYL
29
4
JCI
44
7
GWW
50
9
FOXA
67
5
BAX
38
2
Financhill
Back

Matinas BioPharma Holdings 10K Form

Sell
22

MTNB
Matinas BioPharma Holdings

Last Price:
$0.54
Seasonality Move:
13.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MTNB News And Ratings

See the #1 stock for the next 7 days that we like better than MTNB

MTNB Financial Statistics

Sales & Book Value

Annual Sales: $1.1M
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $3.10
Price / Book: 0.18

Profitability

EPS (TTM): -4.79000
Net Income (TTM): $-21.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Matinas BioPharma Holdings Earnings Forecast

Key Matinas BioPharma Holdings Financial Ratios

  • The Research & Development expenses have been 1,321.99% of Revenue.
  • The Net Earning history of MTNB is -2,093.25% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Matinas BioPharma Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: MTNB
Website: matinasbiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MTNB Technical Analysis vs Fundamental Analysis

Sell
22
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy or a Sell?